...
首页> 外文期刊>Acta gastro-enterologica Belgica >The prognostic significance of clinicopathological features and apoptosis inhibitor proteins in pancreas ductal adenocarcinoma
【24h】

The prognostic significance of clinicopathological features and apoptosis inhibitor proteins in pancreas ductal adenocarcinoma

机译:胰腺导管腺癌的临床病理特征和凋亡抑制蛋白的预后意义

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Pancreas ductal adenocarcinoma (PDAC) is among tumors with unfavorable prognosis. The aim of this study was to determine potential prognostic factors in PDAC. Materials and methods: We retrospectively evaluated a total of 117 cases according to clinicopathological parameters and survivin and livin expression. We investigated the relationship between these parameters and their prognostic significance. Results: In univariate analysis, lymph node metastasis, surgical margin positivity, tumor size over 4 cm and survivin expression were associated with poorer survival but livin expression was not correlated with survival-time. In multivariate analysis, only lymph node metastasis was independent factor predicting a poorer outcome. Conclusions: In present study, the lymph node metastasis was the strongest predictor of survival. Our finding suggest that survivin could be a target for the treatment of advanced stage resectable PDAC. Our results need to be supported by studies on larger series with advanced techniques.
机译:简介:胰腺导管腺癌(PDAC)是预后不良的肿瘤之一。这项研究的目的是确定PDAC中潜在的预后因素。材料和方法:我们根据临床病理参数以及survivin和livin表达进行回顾性评估,共117例。我们调查了这些参数与其预后意义之间的关系。结果:在单变量分析中,淋巴结转移,手术切缘阳性,肿瘤大小超过4 cm和survivin表达与较差的生存率有关,而livin表达与生存时间无关。在多变量分析中,只有淋巴结转移是预后较差的独立因素。结论:在本研究中,淋巴结转移是生存的最强预测因子。我们的发现表明,survivin可能是晚期可切除PDAC的治疗靶标。我们的研究结果需要大量采用先进技术进行的研究的支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号